⌘K
Loading ticker…
Tvardi Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Tvardi Therapeutics, Inc. Common Stock (TVRD) has a 3-month relative strength percentile of 4 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 26. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.9%, relative volume 32.39×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
4 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TVRD is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -53.2% / -80.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
TVRD is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $822K notional. Top 3 carry $2M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $822K |
| IWMiShares Russell 2000 ETF | 0.00% | $518K |
| VXFVanguard Extended Market ETF | 0.00% | $274K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $13K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TVRD Jan avg: -7.67% median: -7.67% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Feb avg: 0.50% median: 0.50% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Mar avg: -20.30% median: -20.30% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Apr avg: 17.86% median: 17.86% win: 50% σ: 26.60% n: 2 2025-04-17 → 2026-05-29 | TVRD May avg: 10.47% median: 10.47% win: 100% σ: 4.48% n: 2 2025-04-17 → 2026-05-29 | TVRD Jun avg: -17.68% median: -17.68% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 (current) | TVRD Jul avg: 11.27% median: 11.27% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Aug avg: 15.25% median: 15.25% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Sep avg: 30.25% median: 30.25% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Oct avg: -88.07% median: -88.07% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Nov avg: -11.40% median: -11.40% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 | TVRD Dec avg: 4.37% median: 4.37% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-05-29 |